Among the most merciless of human diseases, glioblastoma has long defeated medicine not through brute resistance but through invisibility — tumor cells dispersing into healthy tissue beyond the reach of any blade or drug. Researchers from the University of Technology Sydney, Harvard, and Henan universities have now published work in Science Translational Medicine describing nanoparticles engineered to do two things at once: illuminate what surgeons cannot see, then destroy what they cannot safely remove. In mouse models, the approach produced complete survival where surgery alone could not, of
Dual-function nanoparticles show promise in glioblastoma surgery and treatment
Glioblastoma remains one of the most lethal brain cancers with only 7% five-year survival, affecting thousands of patients annually.